AIM Delisting

AIM Delisting


On 2 April 2024, Redx Pharma plc (the “Company” or “Redx”) announced the proposed cancellation of admission of its ordinary shares to trading on AIM, re-registration as a private limited company and adoption of new articles of association (the “Proposed Cancellation and Re-registration”).

A copy of the RNS announcement can be found here.

A copy of the circular can be found here.

On 19 April 2024, the Company announced that, at the general meeting of the Company held on 19 April 2024, all resolutions put to the Company’s shareholders with respect to the Proposed Cancellation and Re-Registration were duly passed and the admission of the Company’s ordinary shares to trading on AIM would be cancelled.

A copy of the RNS announcement can be found here.

As announced, the last day of trading in the Company’s ordinary shares on AIM was 30 April 2024 and the Company’s ordinary shares were cancelled from admission to trading on AIM effective 7:00 a.m. on 1 May 2024.

Matched Bargain Facility

The Company has appointed JP Jenkins to facilitate trading in the ordinary shares. More information can be found here.